• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2008-2018 年中国浙江地区耐碳青霉烯肠杆菌科细菌的流行情况、危险因素及分子流行病学研究。

Prevalence, risk factors and molecular epidemiology of carbapenem-resistant in patients from Zhejiang, China, 2008-2018.

机构信息

Clinical Microbiology Laboratory, 2nd Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.

Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, People's Republic of China.

出版信息

Emerg Microbes Infect. 2020 Dec;9(1):1771-1779. doi: 10.1080/22221751.2020.1799721.

DOI:10.1080/22221751.2020.1799721
PMID:32689907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7475806/
Abstract

Carbapenem-resistant (CRKP) is emerging as a worldwide public health concern; however, the long-term molecular epidemiological surveillance of clinical CRKP in China is limited. We conducted a retrospective observational study (2008-2018) to assess the prevalence, susceptibility, risk factors and molecular epidemiology of clinical CRKP isolates. We found the prevalence of CRKP increased from 2.5%, 2008 to 15.8%, 2018. CRKP were significantly more frequent among hospitalized patients from ICU, and it was significantly more likely to be isolated from the capital city (Hangzhou) and the patients aged ≥60 years. Additionally, seasons and specimen types were associated with CRKP infections The main CRKP sequence type (ST) was ST11, and was the most prevalent gene variant. Together these data reveal an increasing incidence and resistance trends among CRKP, especially the ST11- -CRKP, in Zhejiang, during 2008-2018. Our findings are important for hospitals to limit its dissemination and optimize antibiotic administration.

摘要

耐碳青霉烯肠杆菌科细菌(CRKP)的出现对全球公共卫生构成了威胁;然而,中国临床耐碳青霉烯肠杆菌科细菌的长期分子流行病学监测十分有限。本研究通过回顾性观察研究(2008-2018 年)评估了临床耐碳青霉烯肠杆菌科细菌分离株的流行率、药敏性、危险因素和分子流行病学。结果发现,耐碳青霉烯肠杆菌科细菌的流行率从 2008 年的 2.5%上升至 2018 年的 15.8%。耐碳青霉烯肠杆菌科细菌更常从 ICU 住院患者中分离,且更可能从省会城市(杭州)和 60 岁以上患者中分离。此外,季节和标本类型与耐碳青霉烯肠杆菌科细菌感染有关。主要的耐碳青霉烯肠杆菌科细菌序列型为 ST11,blakpc-2 是最常见的基因变异。这些数据表明,2008-2018 年期间,浙江地区耐碳青霉烯肠杆菌科细菌的发病率和耐药性呈上升趋势,尤其是 ST11- -CRKP。这些发现对医院限制其传播和优化抗生素管理非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/3cc66d96d5fb/TEMI_A_1799721_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/7e09eb5b4cba/TEMI_A_1799721_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/f67c3d70b47a/TEMI_A_1799721_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/ad460390f937/TEMI_A_1799721_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/3cc66d96d5fb/TEMI_A_1799721_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/7e09eb5b4cba/TEMI_A_1799721_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/f67c3d70b47a/TEMI_A_1799721_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/ad460390f937/TEMI_A_1799721_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91b4/7475806/3cc66d96d5fb/TEMI_A_1799721_F0004_OC.jpg

相似文献

1
Prevalence, risk factors and molecular epidemiology of carbapenem-resistant in patients from Zhejiang, China, 2008-2018.2008-2018 年中国浙江地区耐碳青霉烯肠杆菌科细菌的流行情况、危险因素及分子流行病学研究。
Emerg Microbes Infect. 2020 Dec;9(1):1771-1779. doi: 10.1080/22221751.2020.1799721.
2
Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China.中国上海一家综合医院中产 KPC-2 的 ST11 型肺炎克雷伯菌的出现和定植。
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):293-299. doi: 10.1007/s10096-017-3131-4. Epub 2017 Dec 27.
3
Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital.中国一家三甲医院综合和急诊重症监护病房携带碳青霉烯类耐药的肺炎克雷伯菌 ST11 株的传播。
J Med Microbiol. 2019 Jun;68(6):882-889. doi: 10.1099/jmm.0.000981. Epub 2019 May 3.
4
Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study.中国碳青霉烯类耐药肺炎克雷伯菌的流行病学和主要克隆 ST11 的演变趋势:一项基于基因组的多中心研究。
J Antimicrob Chemother. 2024 Sep 3;79(9):2292-2297. doi: 10.1093/jac/dkae227.
5
Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.中国血流感染碳青霉烯类耐药肺炎克雷伯菌的多中心基因组分析。
Microbiol Spectr. 2022 Apr 27;10(2):e0229021. doi: 10.1128/spectrum.02290-21. Epub 2022 Mar 1.
6
Shift in the dominant sequence type of carbapenem-resistant Klebsiella pneumonia infection from ST278-NDM-1 to ST11-KPC-2 in neonatal patients in a children's hospital in Shanghai, China, 2017-2021.2017年至2021年中国上海一家儿童医院新生儿患者中耐碳青霉烯类肺炎克雷伯菌感染的优势序列型从ST278-NDM-1转变为ST11-KPC-2 。
Int Microbiol. 2024 Jun;27(3):871-881. doi: 10.1007/s10123-023-00436-z. Epub 2023 Oct 19.
7
[Carbapenemase Genes, Virulence Genes, and Molecular Epidemiology of Carbapenem-Resistant Derived From Bloodstream Infections].[血流感染来源的耐碳青霉烯类细菌的碳青霉烯酶基因、毒力基因及分子流行病学]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 20;55(2):391-396. doi: 10.12182/20240360202.
8
Outbreak by Hypermucoviscous ST11 Isolates with Carbapenem Resistance in a Tertiary Hospital in China.中国一家三级医院中具有碳青霉烯类耐药性的高黏液性 ST11 分离株引起的暴发。
Front Cell Infect Microbiol. 2017 May 16;7:182. doi: 10.3389/fcimb.2017.00182. eCollection 2017.
9
Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.中国武汉耐碳青霉烯类肺炎克雷伯菌血流感染的分子流行病学及危险因素
Curr Med Sci. 2022 Feb;42(1):68-76. doi: 10.1007/s11596-021-2480-5. Epub 2022 Jan 4.
10
Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.中国安徽产 KPC-2、SHV-106 和 CTX-M-15 型碳青霉烯类耐药肺炎克雷伯菌 ST15 的流行病学研究。
BMC Microbiol. 2022 Nov 1;22(1):262. doi: 10.1186/s12866-022-02672-1.

引用本文的文献

1
Hypervirulent Carbapenem-resistant Infection: Epidemiology, Virulence, Resistance, and Treatment.高毒力碳青霉烯耐药感染:流行病学、毒力、耐药性及治疗
Infect Drug Resist. 2025 Sep 4;18:4689-4697. doi: 10.2147/IDR.S534490. eCollection 2025.
2
Genome Sequencing and Comparative Genomic Analysis of Multidrug-Resistant in a Neurological Intensive Care Unit.神经重症监护病房中耐多药菌的全基因组测序及比较基因组分析
Infect Drug Resist. 2025 Aug 12;18:4067-4086. doi: 10.2147/IDR.S528440. eCollection 2025.
3
Molecular and virulence differences of isolated from blood.

本文引用的文献

1
A 7-year surveillance of the drug resistance in Klebsiella pneumoniae from a primary health care center.某基层医疗中心 7 年耐碳青霉烯肺炎克雷伯菌耐药监测。
Ann Clin Microbiol Antimicrob. 2019 Nov 9;18(1):34. doi: 10.1186/s12941-019-0335-8.
2
Emergence of ceftazidime-avibactam-resistant during treatment, Finland, December 2018.2018 年 12 月,芬兰在治疗期间出现对头孢他啶-阿维巴坦耐药的 。
Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1900256.
3
Emergence of OXA-232 Carbapenemase-Producing That Carries a pLVPK-Like Virulence Plasmid among Elderly Patients in China.
从血液中分离出的[物质]的分子和毒力差异 。(注:原文中“isolated from blood”前缺少具体所指内容,翻译为“[物质]”以便使句子相对完整通顺,但确切含义需根据完整原文确定)
Front Microbiol. 2025 Jul 30;16:1650010. doi: 10.3389/fmicb.2025.1650010. eCollection 2025.
4
Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review.产肺炎克雷伯菌碳青霉烯酶(KPC)革兰阴性临床分离株的全球流行病学及抗菌药物耐药性:综述
Microorganisms. 2025 Jul 19;13(7):1697. doi: 10.3390/microorganisms13071697.
5
Molecular Characterization of Carbapenemase Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates.耐碳青霉烯类肺炎克雷伯菌分离株中碳青霉烯酶基因的分子特征分析
Curr Microbiol. 2025 Jul 29;82(9):418. doi: 10.1007/s00284-025-04403-x.
6
Genomic epidemiology and anti-biofilm mechanisms of Lactobacillus in ST11 carbapenem-resistant in China.中国 ST11 型耐碳青霉烯类乳酸杆菌的基因组流行病学及抗生物膜机制
Front Microbiol. 2025 Jul 2;16:1619621. doi: 10.3389/fmicb.2025.1619621. eCollection 2025.
7
Molecular epidemiology and clinical characteristics of carbapenem-resistant bloodstream and pneumonia isolates.耐碳青霉烯类血流感染和肺炎分离株的分子流行病学及临床特征
Microbiol Spectr. 2025 Aug 5;13(8):e0063125. doi: 10.1128/spectrum.00631-25. Epub 2025 Jul 9.
8
Drug Resistance and Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae in a Brain and Psychiatric Hospital of South China.华南某脑科及精神专科医院耐碳青霉烯类肠杆菌科细菌的耐药性及流行病学分析
J Clin Lab Anal. 2025 Aug;39(15):e70073. doi: 10.1002/jcla.70073. Epub 2025 Jul 3.
9
A retrospective study of the antimicrobial susceptibility patterns of isolated from urine samples over a decade in South India.一项对印度南部十年间从尿液样本中分离出的菌株的抗菌药敏模式的回顾性研究。
Front Microbiol. 2025 Jun 17;16:1553943. doi: 10.3389/fmicb.2025.1553943. eCollection 2025.
10
Predictive model for carbapenem-resistant Klebsiella pneumoniae bloodstream infection based on a nomogram: a retrospective study.基于列线图的耐碳青霉烯类肺炎克雷伯菌血流感染预测模型:一项回顾性研究
BMC Res Notes. 2025 Jul 1;18(1):265. doi: 10.1186/s13104-025-07325-w.
产 OXA-232 碳青霉烯酶 携带 pLVPK 样毒力质粒的老年患者在中国出现。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02246-18. Print 2019 Mar.
4
Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing.北京五家大型重症监护病房医护人员、环境与患者中产碳青霉烯类耐药肺炎克雷伯菌的传播的前瞻性调查。
J Hosp Infect. 2019 Feb;101(2):150-157. doi: 10.1016/j.jhin.2018.11.019. Epub 2018 Dec 6.
5
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
6
Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria.肺炎克雷伯菌作为耐药基因从环境向临床重要细菌传播的关键媒介。
Curr Opin Microbiol. 2018 Oct;45:131-139. doi: 10.1016/j.mib.2018.04.004. Epub 2018 May 1.
7
Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria.改善耐碳青霉烯类革兰氏阴性菌所致感染治疗的证据。
Lancet Infect Dis. 2018 Apr;18(4):358-360. doi: 10.1016/S1473-3099(18)30112-9. Epub 2018 Feb 16.
8
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.发现、研究和开发新抗生素:世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.
9
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.中国医院中致命的 ST11 碳青霉烯类耐药超毒力肺炎克雷伯菌爆发:一项分子流行病学研究。
Lancet Infect Dis. 2018 Jan;18(1):37-46. doi: 10.1016/S1473-3099(17)30489-9. Epub 2017 Aug 29.
10
Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.耐碳青霉烯类肺炎克雷伯菌感染的危险因素:一项荟萃分析。
Microb Drug Resist. 2018 Mar;24(2):190-198. doi: 10.1089/mdr.2017.0061. Epub 2017 Jul 27.